794 filings
Page 9 of 40
4
Jane H Hollingsworth
2 Sep 22
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
9:06pm
4
Raven Jaeger
26 Aug 22
Diffusion Pharmaceuticals / RAVEN JAEGER ownership change
6:08pm
3
Raven Jaeger
26 Aug 22
Diffusion Pharmaceuticals / RAVEN JAEGER ownership change
6:06pm
8-K
CRVO
CervoMed Inc.
16 Aug 22
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
4:21pm
S-8
CRVO
CervoMed Inc.
12 Aug 22
Registration of securities for employees
4:06pm
10-Q
2022 Q2
CRVO
CervoMed Inc.
Quarterly report
11 Aug 22
8:20pm
4
Cobuzzi Robert Joseph Jr.
3 Aug 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
5:52pm
8-K
CRVO
CervoMed Inc.
27 Jul 22
Other Events
7:30am
8-K
CRVO
CervoMed Inc.
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
424B5
CRVO
CervoMed Inc.
22 Jul 22
Prospectus supplement for primary offering
4:15pm
8-K
CRVO
CervoMed Inc.
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
4
Jane H Hollingsworth
2 Jun 22
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:37pm
8-K
CRVO
CervoMed Inc.
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
CRVO
CervoMed Inc.
16 May 22
Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
10-Q
2022 Q1
CRVO
CervoMed Inc.
Quarterly report
12 May 22
4:23pm
8-K
CRVO
CervoMed Inc.
4 May 22
Other Events
4:33pm
4
Cobuzzi Robert Joseph Jr.
3 May 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
6:24pm
4
Cobuzzi Robert Joseph Jr.
19 Apr 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
5:18pm
4
William Robert Elder
19 Apr 22
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
5:17pm
8-K
CRVO
CervoMed Inc.
18 Apr 22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
4:25pm